Company

Fagron NV

Headquarters: Nazareth, Belgium

Employees: 2,712

CEO: Mr. Rafael Padilla

FSX: 4A5

Market Cap

€1.32 Billion

EUR as of July 1, 2024

US$1.41 Billion

Market Cap History

Fagron NV market capitalization over time

Evolution of Fagron NV market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Fagron NV

Detailed Description

Fagron NV, a pharmaceutical compounding company, provides personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients. It prepares personalized ready-to-use medication in its sterile and non-sterile compounding facilities. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it offers pharmaceutical raw materials, equipment, and supplies that pharmacists need to prepare medication in the pharmacy. Further, the company develops, manufactures, and supplies mixing equipment that pharmacists can use for the compounding of semi-solid dermatological formulations. It has operations in Europe, the Americas, the Middle East, and Africa, as well as Asia and the Pacific. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Fagron NV has the following listings and related stock indices.


Stock: FSX: 4A5 wb_incandescent

Stock: OTC: ARSUF wb_incandescent

Details

Headquarters:

Venecoweg 20A

Nazareth, 9810

Belgium